Back to search

Article

Assessing PARP trapping dynamics in ovarian cancer using a CRISPR-engineered FRET biosensor

2025-03-14

Abstract excerpt

Poly(ADP-ribose) polymerase inhibitors (PARPi) have revolutionised the treatment of ovarian high grade serous carcinoma (HGSC), especially those with defective homologous recombination. However, the emergence of resistance poses a critical challenge, as over 50% of patients relapse within three years. The mechanisms underlying changes in PARP trapping, a central aspect of PARPi efficacy, are not well understood du...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4e249aa5-61d4-5cc7-96d8-4e5e2bb9d35c
DOI
10.1101/2025.03.12.642798
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Assessing PARP trapping dynamics in ovarian cancer using a CRISPR-engineered FRET biosensorDOI 10.1101/2025.03.12.642798
Select a neighboring publication to make it the new centre.